|Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers|
A Heravi-Moussavi, MS Anglesio, SWG Cheng, J Senz, W Yang, ...
New England Journal of Medicine 366 (3), 234-242, 2012
|Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling|
A Bashashati, G Ha, A Tone, J Ding, LM Prentice, A Roth, J Rosner, ...
The Journal of pathology 231 (1), 21-34, 2013
|Use of mutation profiles to refine the classification of endometrial carcinomas|
MK McConechy, J Ding, MCU Cheang, KC Wiegand, J Senz, AA Tone, ...
The Journal of pathology 228 (1), 20-30, 2012
|Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention|
JN McAlpine, GE Hanley, MMM Woo, AA Tone, N Rozenberg, ...
American journal of obstetrics and gynecology 210 (5), 471. e1-471. e11, 2014
|Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles|
MK McConechy, J Ding, J Senz, W Yang, N Melnyk, AA Tone, LM Prentice, ...
Modern pathology 27 (1), 128-134, 2014
|Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer|
CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ...
Nature genetics 49 (5), 680-691, 2017
|Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma|
AA Tone, H Begley, M Sharma, J Murphy, B Rosen, TJ Brown, PA Shaw
Clinical Cancer Research 14 (13), 4067-4078, 2008
|Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes|
YK Wang, A Bashashati, MS Anglesio, DR Cochrane, DS Grewal, G Ha, ...
Nature genetics 49 (6), 856-865, 2017
|The role of the fallopian tube in ovarian cancer|
AA Tone, S Salvador, SJ Finlayson, AV Tinker, JS Kwon, CH Lee, ...
Clin Adv Hematol Oncol 10 (5), 296-306, 2012
|The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift|
CJ Reade, RM McVey, AA Tone, SJ Finlayson, JN McAlpine, ...
Journal of obstetrics and gynaecology Canada 36 (2), 133-140, 2014
|Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline …|
SE Ferguson, M Aronson, A Pollett, LR Eiriksson, AM Oza, S Gallinger, ...
Cancer 120 (24), 3932-3939, 2014
|Risk-reducing salpingectomy in Canada: a survey of obstetrician-gynaecologists|
CJ Reade, S Finlayson, J McAlpine, AA Tone, M Fung-Kee-Fung, ...
Journal of Obstetrics and Gynaecology Canada 35 (7), 627-634, 2013
|BAF250a expression in atypical endometriosis and endometriosis-associated ovarian cancer|
JP Stamp, CB Gilks, M Wesseling, S Eshragh, K Ceballos, MS Anglesio, ...
International Journal of Gynecologic Cancer 26 (5), 2016
|Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas|
AA Tone, MK McConechy, W Yang, J Ding, S Yip, E Kong, KK Wong, ...
BMC cancer 14 (1), 1-13, 2014
|Ovarian Cancer Research Program of British Columbia. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention|
JN McAlpine, GE Hanley, MM Woo, AA Tone, N Rozenberg, ...
Am J Obstet Gynecol 210 (471), e1-471, 2014
|Prolonged postovulatory proinflammatory signaling in the fallopian tube epithelium may be mediated through a BRCA1/DAB2 axis|
AA Tone, C Virtanen, P Shaw, TJ Brown
Clinical cancer research 18 (16), 4334-4344, 2012
|Altered expression of inflammation-associated genes in oviductal cells following follicular fluid exposure: implications for ovarian carcinogenesis|
A Lau, A Kollara, ES John, AA Tone, C Virtanen, EM Greenblatt, WA King, ...
Experimental biology and medicine 239 (1), 24-32, 2014
|Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis|
SHL George, A Milea, R Sowamber, R Chehade, A Tone, PA Shaw
Oncogene 35 (1), 59-68, 2016
|Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma|
AA Tone, C Virtanen, PA Shaw, TJ Brown
Endocrine-related cancer 18 (2), 221-234, 2011
|Low-grade and high-grade serous Mullerian carcinoma: review and analysis of publicly available gene expression profiles|
T May, M Shoni, CP Crum, W Xian, V Vathipadiekal, M Birrer, B Rosen, ...
Gynecologic oncology 128 (3), 488-492, 2013